|Day Low/High||73.61 / 75.40|
|52 Wk Low/High||61.35 / 82.52|
Shares of Merck are falling in Monday trading after the company's attempt to develop a Hepatitis C drug that would reduce treatment duration has fallen short.
These data will indicate if things are going to perk up or if we are in for more warnings.
The flood doesn't look to slow down anytime soon -- and these top underwriters are set to benefit.
Let's take a peek at overnight and early-morning price action in the major asset classes. Exit light Enter night Take my hand We're off to never never land. -- Metallica, "Enter Sandman" Let's take a peek at overnight and early-morning price action ...
TheStreet Quant Ratings upgrades Guess? and Piper Jaffray. Brittany Umar details today's upgrades and downgrades.